Hwang Kuk Hyoun 4
4 · Bellevue Life Sciences Acquisition Corp. · Filed Feb 23, 2023
Insider Transaction Report
Form 4
Hwang Kuk Hyoun
DirectorPresident and CEO10% Owner
Transactions
- Other
Common Stock
2023-02-21+225,000→ 2,025,000 total(indirect: By LLC) - Other
Common Stock
2023-02-21−4,500→ 2,020,500 total(indirect: By LLC)
Footnotes (3)
- [F1]Represents shares of common stock held by Bellevue Global Life Sciences Investors LLC the sponsor of the Issuer (the "Sponsor"), whose general partner is Bellevue Capital Management LLC ("Bellevue Capital"). Kuk Hyoun Hwang is the managing partner of Bellevue Capital and has voting and dispositive power over the shares held by the Sponsor.
- [F2]Represents the shares that will no longer be forfeited by the Sponsor as a result of the underwriters exercising the over-allotment option in full.
- [F3]Represents an additional 4,500 shares that were transferred from the Sponsor to the underwriters as a result of the underwriters exercising the over-allotment option in full.